Lump under the angle of the jaw
A lump on the side of the neck that does not hurt and grows slowly.
Discuss your case Hemodectoma of the neck is a rare tumor of the carotid body, a tiny cluster of cells where the carotid artery divides into two branches. It is mostly benign and slow-growing, but lies on large vessels and near nerves, so treatment decisions are made carefully.
CONCEPTUAL VISUALIZATIONHemodectoma, or paraganglioma, is a rare neuroendocrine tumor. On the neck, it grows from the carotid body — a small cluster of cells in the place where the common carotid artery divides into the internal and external. Such tumors also occur on the vagus nerve or near the ear.
For the most part, chemodectoma is benign and grows slowly. In a cohort of 159 head and neck tumors, over a median follow-up of 63.6 months, 44% increased, and carotid body tumors grew at a median rate of 1.6 mm per year. Malignancy is rare: in a pooled analysis of 155 studies, 6% of tumors were malignant or metastasized or recurred.
The difficulty lies in where it lies. The tumor lies between the branches of the carotid artery and can cover them, and cranial nerves pass nearby, which depend on swallowing, voice and tongue movements. Therefore, both the tumor and its treatment can affect these structures.
Two more features: some chemodectomas are hereditary, and some secrete hormones. Therefore, the examination is not limited to the neck.
This is general information. The doctor will tell you what will suit you after the examination and examinations.
Often a person simply feels a lump on the neck. In a meta-analysis of 104 studies (4,418 patients), this was the case in 75% of cases, and 85% of these nodules did not hurt.
A lump on the side of the neck that does not hurt and grows slowly.
Difficulty swallowing, damage to cranial nerves, or headache at the time of treatment were experienced by 3% of patients.
In a pooled analysis of 9,291 patients, 13% had tumors on both sides of the neck, and 16% had multiple paragangliomas in different locations.
In the pooled analysis, 12% of tumors were hormonally active. Excess hormones can cause headaches, sweating, palpitations and high blood pressure.
The main known factor is heredity. Reviews also pay attention to the gender and age of patients.
Hereditary changes in succinate dehydrogenase (SDH) genes are considered the main genetic factors in the review. In the combined analysis, 36% of patients had them, 16% had a family history.
In carriers of SDHD gene changes, paragangliomas mainly occur on the head and neck, and in almost 20%, they also occur in other places of the body.
65% of the operated patients were women; reviews call female gender a risk factor.
In a meta-analysis of 4418 patients, the mean age of patients was 47 years.
Compaction itself usually does not require emergency care: in a meta-analysis of 4,418 patients, stroke as the first sign of a tumor occurred in 0.09%, microstroke — in 0.26%. But the tumor lies on the carotid artery, so signs of a stroke, especially after surgery, are a reason to call 103.
Immediately - to the surgeon who operated, and if it does not work - to the waiting room: after the operation, swelling or pain grows near the wound, and it is not difficult to breathe and swallow. On the same day: after surgery, pus or blood is released from the wound, it is swollen and painful; high fever or chills. In the coming days: a lump on the side of the neck does not pass for 2 weeks, grows or is firm and does not move; repeated attacks of headache, sweating and palpitations. Planned: there are already paragangliomas or changes in SDH genes in the family - discuss the examination with the doctor.
Since when there is a compaction, is it growing, are there attacks of sweating and palpitations, have there been paragangliomas in the family.
The British consensus advises an MRI not only of the neck, but also of the head, chest, abdomen and pelvis — so as not to miss other tumors.
Blood or urine for hormone breakdown products show whether the tumor is hormonally active. The guideline advises to do this analysis at the very beginning, before any intervention - surgery, embolization or biopsy: if the tumor secretes hormones, preparation with drugs is required before the intervention to avoid complications.
The guidelines recommend considering genetic testing for all patients, and testing for SDHx genes in paraganglioma.
According to the images, it is estimated how tightly the tumor covers the carotid arteries: class I, II or III. The risk of the operation depends on this.
There is no single way. The British consensus advises for most head and neck tumors to start with surveillance, and a meta-analysis by Shamblin class suggests that surgery is an acceptable option for class I and II tumors. The plan depends on the size and grade of the tumor, age, heredity, and whether it secretes hormones, and is made by a team of specialists.
When the tumor is small and does not bother.
Removal of a tumor from under the carotid artery.
The higher, denser the tumor covers the arteries.
At Dr. Valikhnovskyi's Institute of Surgery, soft tissue tumors and soft tissue tumors of the neck are examined in the "Soft Tissue Oncology" department. In the case of chemodectomy, the clinic is responsible for its part — consultation, assessment of images and plan; hormone analysis and genetic testing are conducted by an endocrinologist and geneticist, irradiation by a radiation therapist. Whether an operation is necessary and who will perform it is decided after examinations.
Plastic surgeon, candidate of medical sciences, founder of Dr. Valikhnovskyi Institute of Surgery.
Short answers. What is right for you, the doctor will tell you during the consultation.
Mostly no. In a pooled analysis of 9,291 patients, 6% of tumors were malignant or metastasized or recurred, in a review of malignant tumors, 7.3%. The examination advises to suspect a malignant tumor if it is more than 4 cm, class III, painful, is present on both sides, or is associated with SDH gene changes.
No. The British consensus advises for most head and neck tumors to be surveillance first, for those that are growing, mostly radiation, and surgery has a limited role. For class I and II tumors, a meta-analysis considers surgery to be an acceptable option. Decisions are made individually.
The tumor lies on the carotid artery next to the nerves. In a meta-analysis of 4,418 patients, 11.15% had persistent nerve damage after 30 days, 3.53% had a stroke within 30 days, and 2.29% died within 30 days. The denser the tumor covers the arteries, the higher the risk.
Part of chemodectoma is hereditary: in the pooled analysis, 36% of patients had SDH gene changes. The result depends on how you will be monitored and whether relatives will be tested: in high-risk groups, the British consensus considers testing relatives mandatory.
Obstruction of tumor vessels through angiography before surgery. Data on its benefits differ, so it is done by the decision of the team, not everyone.
Thus, the risk of new tumors persists for years, especially with hereditary forms. Therefore, the European guideline advises follow-up for at least 10 years, and for high-risk patients every year for life.
Yes, if the tumor is small and not bothersome: the British consensus calls surveillance the first choice for most head and neck tumors. In a follow-up cohort of 47 tumors with dynamic imaging, 66% did not enlarge. But surveillance requires regular MRIs and does not always prevent complications.
The figures on the page are from these sources.
Send pictures of the neck and discharge. The doctor will evaluate whether it looks like a chemodectoma and tell what tests are needed next.
Leave your contact details and briefly describe the situation. A coordinator will contact you to agree on the next step.